|
WO2020060412A1
|
|
Phosphonate-containing crosslinkers
|
|
EP3811081A1
|
|
Method for monitoring kinase activity in a sample
|
|
EP3581168A1
|
|
Sustained release composition
|
|
WO2018197445A1
|
|
Antimicrobial peptides and their use
|
|
WO2016135268A1
|
|
Method for preparing a chemical compound using a ruthenium metal catalyst on a zirconium oxide support in the presence of a contaminant
|
|
CA2972836A1
|
|
Nisin-based compounds and use thereof in the treatment of bacterial infections
|
|
WO2016022028A1
|
|
Mutant porcine epizootic diarrhea virus for use in a vaccine
|
|
CN106488929A
|
|
Novel C ATH2 derivant
|
|
WO2015026234A1
|
|
Supported metal nanoparticle-based catalyst for the hydrogenation of a levulinic acid source
|
|
NL2013317B1
|
|
Amphiphilic block copolymers for delivery of active agents.
|
|
WO2014017915A2
|
|
Urea and guanidinium derivatives of iminosugars
|
|
CN104159925A
|
|
Bi-specific adapters
|
|
WO2013036130A1
|
|
Broadly neutralizing vhh against hiv-1
|
|
WO2012177138A1
|
|
Process for the liquid-phase reforming of lignin to aromatic chemicals and hydrogen
|
|
WO2012074392A1
|
|
Slidable bushing assembly
|
|
WO2012165944A1
|
|
Hot wire chemical vapour deposition process for producing an inorganic-polymer multi-layer stack
|
|
WO2012018260A1
|
|
Epidermal growth factor receptor targeted immune therapy
|
|
CN103209710A
|
|
Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith
|
|
MX2012011751A
|
|
Recombinant multimeric influenza proteins.
|
|
EP2526209A1
|
|
Means and methods for distinguishing fecv and fipv
|
